Clinical Efficacy Observation of Diabetic Cerebral Infarction Treated with Danhong Injection

Objective To observe the clinical efficacy and safety of danhong injection in treatment of diabetic cerebral infarction.Methods 160 cases of diabetesⅡ and acute cerebral infarction were divided randomly into treatment group(danhong injection group)and control group(venorruton group),80 cases in each group.In control group,venorruton 400mg was dissolved into 0.9% normal saline 250ml for intravenous drop infusion,once per day.In treatment group,danhong injection 40ml was dissolved into 0.9% normal saline 250ml for intravenous drop infusion,once per day.The basic treatment was same in two groups and the course of treatment was 14 days.Before and after treatment,separately,the clinical efficacy and severity of nerve function deficit of patients were assessed.Results The results of basic curing,significant improvement and total effective rate in treatment group were advantageous apparently than those in control group,indicating statistical significant difference(P0.05).The score of nerve function deficit in treatment group decreased apparently as compared with that in control group,indicating statistical significant difference(P0.01).Conclusion Danhong injection has definite,safe and reliable effect on diabetes and acute cerebral infarction and deserves to be promoted in clinic.